coronavirus vaccine is to resume after a short pause when a participant in the UK became unwell.The university announced on Saturday that the trial was to resume and that "some 18,000 individuals" globally had received study vaccines as part of the trial.The vaccine is being developed by AstraZeneca and Oxford University and was only halted on Tuesday night as a result of a reported side-effect in a participant in the UK.AstraZeneca issued a statement on Tuesday night saying the late-stage studies of the vaccine had been paused while the company investigated whether the patient’s reported side effect is connected with the vaccine.Get the latest updates from across Greater Manchester direct to your inbox with the free MEN newsletterYou can.